Black Diamond Therapeutics, Inc. ( BDTX) - Key Metrics
BDTX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.17 | -$0.12 | -$0.12 |
| 2026Q1 | $0 | -$0.16 | -$0.18 | -$0.18 |
| 2025Q4 | $0 | -$0.26 | -$0.12 | -$0.12 |
| 2025Q3 | $0 | -$0.15 | -$0.14 | -$0.14 |
| 2025Q2 | $0 | -$0.19 | -$0.16 | -$0.16 |
BDTX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.72 |
| 2026Q1 | 0% | -3.33 |
| 2025Q4 | 0% | -2.34 |
| 2025Q3 | 0% | -6.32 |
| 2025Q2 | 0% | -3.26 |
BDTX
Price: $2.02
52 week price:
Earnings Per Share: -0.75 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 81500
Market Capitalization: 120.3 million